Below is the Internal Factor Evaluation (IFE) Matrix for Fresenius Inc., a leading medical services provider. Analyze and interpret the information for meaningful managerial insights. Briefly explain FOUR (4) conclusions from the analysis.

Strengths 1. Sales and earnings per share have not declined a single year for 10 years 2. Fresenius Medical Care is the market leader in dialysis services and products 3. Trading volume increased by 17 percent in 2011 4. Dividends were just raised for the 20th consecutive year 5. Financial analysts ratings show 23 "buy," 2 "hold," and no sell 6. Has a renown training school for nurses and other health workers 7. DAX30 ranking in market capitalization steadily improving 8. Fresenius Medical increased worldwide clinics by 6 percent 9. Fresenius Helios is the second largest private hospital operators in Germany 10. Diversified 4 business segments in different healthcare sectors Weaknesses Weight Rating WScore 0.09 4 0.36 0,09 4 0.36 0.045 3 0.15 0.06 + 0.24 0.06 0.18 0.03 0.09 0.05 4 0.20 0.03 3 0.09 0.06 0.18 0.05 0.15 w 3 N N 1. Quick Ratio of 0.65 shows a lack of ability to cover cash needs 2. Group sales decreased by 4 percent in North America 3. Group debt increased by 9 percent 4. Fresenius Biotech has a negative EBIT of approx. $38.6 million 5. Decrease of 21% in operating cash flow from 2010 to 200 6. Fresenius Helios dropped 3.1 billion euro takeover of rival Rhoen-Klinikum on September 3, 2012, because of rival hospital operators blocking the merger 7. Fresenius Vamed made no material acquisitions 8. No racial diversity on management and supervisory boards 9. Healthcare Group board members and committees comprised of all males 10. Only one female in all top management 0.07 0.03 0.05 0.05 0.08 0.01 0.14 0.06 0.05 0.10 0.08 0.02 2 2 2 2 0.02 0.04 0.04 0.04 0.04 0.08 0.04 0.04 Total 1.0 2.65